W. Ryder

发表

ChlVPP/EVA hybrid versus the weekly VAPEC-B regimen for previously untreated Hodgkin's disease.

T. Lister, R. Gupta, Jenny C. Chang, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Synchronous chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck using capecitabine: a single-centre, open-label, single-group phase II study.

W. Ryder, J. Homer, N. Slevin, 2011, Clinical oncology (Royal College of Radiologists (Great Britain)).

The assessment of irradiated bladder carcinoma using dynamic contrast-enhanced MR imaging.

C. Hutchinson, W. Ryder, C. D. Collins, 2001, Clinical radiology.

Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer

A. Howell, W. Ryder, P. Wilkinson, 2004, British Journal of Cancer.

Patterns of mortality after prolonged follow-up of a randomised controlled trial using granulocyte colony-stimulating factor to maintain chemotherapy dose intensity in non-Hodgkin's lymphoma

J. Radford, W. Ryder, R. Pettengell, 2008, British Journal of Cancer.

Prophylactic Irradiation of Tracts in Patients With Malignant Pleural Mesothelioma: An Open-Label, Multicenter, Phase III Randomized Trial.

W. Ryder, R. Rintoul, C. Faivre-Finn, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The relationship between serum GH and serum IGF-I in acromegaly is gender-specific.

W. Ryder, P. Trainer, C. Parkinson, 2001, The Journal of clinical endocrinology and metabolism.

Fractionated ⁹⁰Y-ibritumomab tiuxetan radioimmunotherapy as an initial therapy of follicular lymphoma: an international phase II study in patients requiring treatment according to GELF/BNLI criteria.

Sam A. Mayes, F. Jardin, D. Huglo, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Content of long‐term culture‐initiating cells, clonogenic progenitors and CD34+ cells in apheresis harvests of normal donors for allogeneic transplantation, and in patients with acute myeloid leukaemia or multiple myeloma

W. Ryder, J. Chang, J. Dürig, 1999, British journal of haematology.

Testicular function after cytotoxic chemotherapy: evidence of Leydig cell insufficiency.

J. Radford, W. Ryder, S. Howell, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Reply to the letter to the editor 'second-line chemotherapy in advanced biliary cancer: the present now will later be past' by Vivaldi et al.

W. Ryder, A. Lamarca, J. Valle, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

A double-blind, placebo-controlled, randomised trial of active manuka honey and standard oral care for radiation-induced oral mucositis.

A. Molassiotis, W. Ryder, N. Slevin, 2012, The British journal of oral & maxillofacial surgery.

Second-line FOLFOX chemotherapy for advanced biliary tract cancer - Authors' reply.

W. Ryder, A. Maraveyas, J. Bridgewater, 2021, The Lancet. Oncology.

Failure of antibody response to polysaccharide antigen in treated panhypopituitary adults

W. Ryder, S. Shalet, R. Borrow, 2008, Clinical and experimental immunology.

A randomised, pragmatic clinical trial of ACUpuncture plus standard care versus standard care alone FOr Chemotherapy Induced peripheral Neuropathy (ACUFOCIN)

W. Ryder, A. Wardley, J. Stringer, 2022, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

A Randomised Phase II Clinical Trial of Acupuncture Plus Standard Care Versus Standard Care Alone for Chemotherapy- Induced Peripheral Neuropathy (CIPN)

W. Ryder, A. Wardley, V. Misra, 2020 .

Prognostic relevance of micro-vessel density in cancer of the urinary bladder.

W. Ryder, N. Clarke, S. Kumar, 1999, Anticancer research.

All‐Trans Retinoic Acid (Atra) and Tranexamic Acid: A Potentially Fatal Combination In Acute Promyelocytic Leukaemia

W. Ryder, J. Chang, R. Chopra, 2000, British journal of haematology.

Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer.

W. Ryder, P. Hasleton, J. Heighway, 1996, British Journal of Cancer.

Survival times of Provox™ valves

W. Ryder, S. Saeed, J. de Carpentier, 1996, The Journal of Laryngology & Otology.

Evaluation of cytogenetic conversion to Ph− haemopoiesis in long‐term bone marrow culture for patients with chronic myeloid leukaemia on conventional hydroxyurea therapy, on pulse high‐dose hydroxyurea and on interferon‐alpha

W. Ryder, J. Chang, T. Dexter, 1996, British journal of haematology.

Heterogeneity of O6-alkylguanine DNA-alkyltransferase expression in human breast tumours

A. Howell, W. Ryder, G. Margison, 2002, British Journal of Cancer.

Carcinomatous meningitis in patients with breast cancer. An aggressive disease variant

A. Howell, G. Jayson, W. Ryder, 1994, Cancer.

Phase II study of cisplatin and imatinib in advanced salivary adenoid cystic carcinoma.

W. Ryder, P. Julyan, T. Ward, 2011, The British journal of oral & maxillofacial surgery.

An integrated genomic approach identifies that the PI3K/AKT/FOXO pathway is involved in breast cancer tumor initiation

R. Bernards, W. Ryder, R. Beijersbergen, 2015, Oncotarget.

Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial

W. Ryder, A. Maraveyas, J. Bridgewater, 2021, The Lancet. Oncology.

748TiPABC-06: A RANDOMISED PHASE III, MULTI-CENTRE, OPEN-LABEL STUDY OF ACTIVE SYMPTOM CONTROL (ASC) ALONE OR ASC WITH OXALIPLATIN / 5-FU CHEMOTHERAPY FOR PATIENTS WITH LOCALLY ADVANCED / METASTATIC BILIARY TRACT CANCERS (ABC) PREVIOUSLY TREATED WITH CISPLATIN / GEMCITABINE CHEMOTHERAPY.

W. Ryder, J. Bridgewater, D. Palmer, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Alternate splicing produces a novel cyclin D1 transcript.

N Thatcher, W. Ryder, J. Heighway, 1995, Oncogene.

Prognostic significance ofCCNDI(cyclin D1)overexpression inprimary resected non-small-cell lung cancer

W. Ryder, D. Betticher, T. Cerny, 1996 .

Assessment and significance of mediastinal bulk in Hodgkin's disease: comparison between computed tomography and chest radiography.

J. Radford, W. Ryder, B. Carrington, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Assessment a nd S ignificance o f M ediastinal B ulk i n Hodgkin's D isease: C omparison B etween C omputed Tomography a nd C hest R adiography

J. Radford, W. Ryder, B. Carrington, 1999 .

A randomised study of adjuvant MVPP chemotherapy after mantle radiotherapy in pathologically staged IA-IIB Hodgkin's disease: 10-year follow-up.

J. Radford, W. Ryder, D. Deakin, 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

Growth hormone and tumour recurrence.

W. Ryder, P. Clayton, H. Gattamaneni, 1992, BMJ.

Growth hormone treatment of children with brain tumors and risk of tumor recurrence.

P. Hindmarsh, W. Ryder, A. Swerdlow, 2000, The Journal of clinical endocrinology and metabolism.

Predicting septic complications of chemotherapy: an analysis of 382 patients treated for small cell lung cancer without dose reduction after major sepsis.

J. Radford, W. Ryder, D. Dodwell, 1992, European journal of cancer.

A randomized, controlled trial of acupuncture self-needling as maintenance therapy for cancer-related fatigue after therapist-delivered acupuncture.

A. Molassiotis, W. Ryder, A. Richardson, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase I trial of the MEK inhibitor selumetinib in combination with thoracic radiotherapy in non-small cell lung cancer

W. Ryder, C. Faivre-Finn, F. Blackhall, 2021, Clinical and translational radiation oncology.

A phase Ib study of NUC-1031 in combination with cisplatin for the first-line treatment of patients with advanced biliary tract cancer (ABC-08).

W. Ryder, J. Bridgewater, D. Palmer, 2020, The oncologist.

Recombinant human granulocyte colony-stimulating factor (filgrastim) following high-dose chemotherapy and peripheral blood progenitor cell rescue in high-grade non-Hodgkin's lymphoma: clinical benefits at no extra cost.

J. Radford, W. Ryder, D. Crowther, 1998, British Journal of Cancer.

Measurement of long-term culture initiating cells (LTC-ICs) using limiting dilution: comparison of endpoints and stromal support.

W. Ryder, A. Weaver, N. Testa, 1997, Experimental hematology.

Treatment outcome and prognostic factors for relapse after high-dose chemotherapy and peripheral blood stem cell rescue for patients with poor risk high grade non-Hodgkin’s lymphoma

W. Ryder, J. Chang, J. Howard Scarffe, 1999, Bone Marrow Transplantation.

The characteristics of quality of life impairment in adult growth hormone (GH)-deficient survivors of cancer and their response to GH replacement therapy.

W. Ryder, S. Shalet, A. Mukherjee, 2005, The Journal of clinical endocrinology and metabolism.

Results of a randomized trial comparing MVPP chemotherapy with a hybrid regimen, ChlVPP/EVA, in the initial treatment of Hodgkin's disease.

A. Oza, R. Gupta, J. Radford, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Isotoxic Intensity Modulated Radiation Therapy in Stage III Non-Small Cell Lung Cancer: A Feasibility Study

W. Ryder, C. Faivre-Finn, S. Harden, 2020, International journal of radiation oncology, biology, physics.

Prolactin deficiency is independently associated with reduced insulin-like growth factor I status in severely growth hormone-deficient adults.

W. Ryder, S. Shalet, A. Mukherjee, 2006, The Journal of clinical endocrinology and metabolism.

Radiotherapy for muscle-invasive carcinoma of the bladder: results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapy.

V. Khoo, W. Ryder, R. Cowan, 2002, International journal of radiation oncology, biology, physics.

Prognostic factors for disease progression in advanced Hodgkin's disease: an analysis of patients aged under 60 years showing no progression in the first 6 months after starting primary chemotherapy.

J. Radford, W. Ryder, D. Deakin, 1997, British Journal of Cancer.

The dispersal of certain species of Mallophaga which infest the domestic fowl Callus domesticus.

W. Ryder, 1967 .

PRE-surgical Metformin In Uterine Malignancy (PREMIUM): a Multi-Center, Randomized Double-Blind, Placebo-Controlled Phase III Trial

H. Kitchener, W. Ryder, P. Pemberton, 2018, Clinical Cancer Research.

Clinical trial protocol: PRednisolone in early diffuse cutaneous Systemic Sclerosis (PRedSS)

W. Ryder, A. Herrick, C. Denton, 2020, Journal of scleroderma and related disorders.

ACUFOCIN: Randomized clinical trial of ACUpuncture plus standard care versus standard care alone FOr Chemotherapy Induced peripheral Neuropathy (CIPN).

W. Ryder, A. Wardley, V. Misra, 2020 .

A phase II trial of low-dose estradiol in postmenopausal women with advanced breast cancer and acquired resistance to aromatase inhibition.

A. Howell, M. Seif, W. Ryder, 2015, European journal of cancer.

Relationship of MRI and clinical staging to outcome in invasive bladder cancer treated by radiotherapy.

C. Hutchinson, W. Ryder, R. Cowan, 2000, Clinical radiology.

Tumor expression of major vault protein is an adverse prognostic factor for radiotherapy outcome in oropharyngeal carcinoma.

I. Hampson, W. Ryder, C. West, 2007, International journal of radiation oncology, biology, physics.

Paradoxical elevations in serum IGF‐II and IGF binding protein‐2 in acromegaly: insights into the regulation of these peptides

W. Ryder, C. Potten, A. Renehan, 2001, Clinical endocrinology.

Semen cryopreservation, utilisation and reproductive outcome in men treated for Hodgkin's disease

W. Ryder, F. Blackhall, D. Brison, 2002, British Journal of Cancer.

Chemoradiotherapy for locally advanced pancreatic cancer: a radiotherapy dose escalation and organ motion study.

W. Ryder, C. Moore, A. Henry, 2008, Clinical oncology (Royal College of Radiologists (Great Britain)).

Massive haemoptysis death and other morbidity associated with high dose rate intraluminal radiotherapy for carcinoma of the bronchus.

W. Ryder, P. Barber, S. Gollins, 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Second-line chemotherapy in advanced biliary cancer: a systematic review.

W. Ryder, A. Lamarca, J. Valle, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Is it time to convert the frequency of radiotherapy in small-cell lung cancer? - Authors' reply.

W. Ryder, C. Faivre-Finn, F. Blackhall, 2017, The Lancet. Oncology.

What is the value of the lateral chest radiograph in the follow-up thoracic lymphoma?

W. Ryder, C. D. Collins, B. Carrington, 1997, European Radiology.

A Phase II randomized controlled trial of oral prednisolone in early diffuse cutaneous systemic sclerosis (PRedSS)

R. Madhok, B. Griffiths, W. Ryder, 2023, Rheumatology.